FDA Adverse Event
Injury
Summary report: N
CURESIGHT
MDR report key: 21170512
·
Received January 16, 2025
Report
- Report Number
- MW5164849
- Event Type
- Injury
- Date Received
- January 16, 2025
- Date of Event
- December 18, 2024
- Report Date
- January 12, 2025
- Manufacturer
- NOVASIGHT
- Product Code
- QQU
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- PATIENT FAMILY MEMBER OR FRIEND
- Health Professional
- *
Narratives
Description of Event or Problem · 0
AFTER MY SON USED THE CURESIGHT DEVICE FOR AMBPLEOPIA TREATMENT, HE STARTED EXPERIENCING SEVERE EYE PAIN, BLURRED VISION, AND A POUNDING HEADACHE. HIS VISION GOT WORSE, AND HE BEGAN VOMITING UNCONTROLLABLY. WE REACHED OUT TO HIS OPHTHALMOLOGIST, WHO ADVISED US TO STOP USING THE DEVICE IMMEDIATELY AND REPORT THE INCIDENT. WE ALSO TRIED CONTACTING THE VENDOR, BUT THE ONLY RESPONSE WE GOT WAS FROM AN UNRELATED CALL CENTER THAT REFUSED TO PROVIDE ANY REAL ANSWER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1056613 | CURESIGHT | DIGITAL THERAPY DEVICE FOR AMBLYOPIA | QQU | NOVASIGHT | CS 100 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 5 YR | Male | Hospitalization| R |